The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predicting progression in patients followed with active surveillance for low-risk prostate cancer.
Itay Aharon Sternberg
No relevant relationships to disclose
Changhong Yu
No relevant relationships to disclose
Gal Elimelech Keren Paz
No relevant relationships to disclose
Philip H. Kim
No relevant relationships to disclose
Melanie Bernstein
No relevant relationships to disclose
Paul Lakin
No relevant relationships to disclose
Michael W. Kattan
No relevant relationships to disclose
Behdar Ehdaie
No relevant relationships to disclose
Vincent Paul Laudone
No relevant relationships to disclose
Peter T. Scardino
No relevant relationships to disclose
James Andrew Eastham
No relevant relationships to disclose
Karim A. Touijer
No relevant relationships to disclose